Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Normal Renal Function”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04209049
What this trial is testing

A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney Function

Who this might be right for
OverweightObesity
Novo Nordisk A/S 33
Early research (Phase 1)Study completedNCT01907113
What this trial is testing

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 40
Early research (Phase 1)Study completedNCT03411980
What this trial is testing

Pharmacokinetics and Safety of Vilaprisan in Renal Impairment

Who this might be right for
Uterine FibroidsEndometriosis
Bayer 26
Early research (Phase 1)Study completedNCT02442258
What this trial is testing

Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal Impairment
AbbVie 46
Early research (Phase 1)Study completedNCT01245790
What this trial is testing

Fostamatinib in Subjects With Impaired Kidney Function

Who this might be right for
Rheumatoid ArthritisRenal Impairment
AstraZeneca 24
Early research (Phase 1)Study completedNCT03687554
What this trial is testing

Effect of Venglustat in Patients With Renal Impairment

Who this might be right for
Healthy VolunteersPolycystic Kidney, Autosomal Dominant
Genzyme, a Sanofi Company 24
Early research (Phase 1)Study completedNCT01443429
What this trial is testing

A Pharmacokinetic Study of TRK-100STP in Japanese Patients With Renal Impairment

Who this might be right for
Renal Impairment
Toray Industries, Inc 24
Early research (Phase 1)Ended earlyNCT04252430
What this trial is testing

RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects

Who this might be right for
Healthy VolunteersImpaired Renal Function
MedDay Pharmaceuticals SA 24
Early research (Phase 1)Study completedNCT01504165
What this trial is testing

Pharmacokinetics in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Merck KGaA, Darmstadt, Germany 32
Not applicableStudy completedNCT00721994
What this trial is testing

Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects

Who this might be right for
OsteoarthritisAvascular NecrosisRheumatoid Arthritis
Corin 231
Early research (Phase 1)Study completedNCT02603497
What this trial is testing

Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function

Who this might be right for
Patients With Impaired Renal Function
Astellas Pharma Inc 31
Early research (Phase 1)Study completedNCT01289080
What this trial is testing

Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects

Who this might be right for
SchizophreniaPsychiatric Disorders
Otsuka Pharmaceutical Development & Commercialization, Inc. 19
Early research (Phase 1)Study completedNCT01904214
What this trial is testing

A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 16
Early research (Phase 1)Study completedNCT01580306
What this trial is testing

Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment

Who this might be right for
Hepatitis C
Boehringer Ingelheim 32
Early research (Phase 1)Study completedNCT01526746
What this trial is testing

Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function

Who this might be right for
Renal Impairment
Vanda Pharmaceuticals 32
Early research (Phase 1)Ended earlyNCT01359579
What this trial is testing

The Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

Who this might be right for
Renal Impairment
Anthera Pharmaceuticals 28
Early research (Phase 1)Study completedNCT03302091
What this trial is testing

A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the Body

Who this might be right for
Renal InsufficiencyHealthy
Boehringer Ingelheim 20
Early research (Phase 1)Study completedNCT02646358
What this trial is testing

Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer

Who this might be right for
Pharmacokinetics of VepoloxamerHealthy VolunteersRenal Impaired
Mast Therapeutics, Inc. 27
Early research (Phase 1)Study completedNCT01708889
What this trial is testing

Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction

Who this might be right for
Chronic Hepatitis B Virus InfectionChronic Hepatitis C Virus Infection
Bristol-Myers Squibb 43
Early research (Phase 1)Study completedNCT01508806
What this trial is testing

Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation